Impact of Decitabine Conditioning on Allo‐HSCT Outcomes in AML and Intermediate‐to‐High‐Risk MDS Patients in Remission

Impact of Decitabine Conditioning on Allo‐HSCT Outcomes in AML and Intermediate‐to‐High‐Risk MDS Patients in Remission

ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) remains the sole curative option for myeloid malignancies, though high toxicity from conditioning regimens and complications like graft‐versus‐host disease (GVHD) limit its success. The potential benefit of incorporat...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuling Yu, Wanchuan Zhuang, Shengfa Gao, Tongyu Li, Xiao Yan, Guifang Ouyang, Ping Zhang
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:Cancer Medicine
Subjects:
allogenic hematopoietic stem cell transplantation
AML
decitabine
graft‐versus‐host disease
MDS
Online Access:https://doi.org/10.1002/cam4.71081
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cam4.71081

Similar Items